Zonghai Li MD, PhD

Zonghai Li, MD, Ph.D., is the founder of CARsgen Therapeutics and served as Chief Executive Officer since the company’s inception in 2014. Dr. Li was also the founder of a series of biotech start-up companies in China. Dr. Li also servers as the tenure Professor at Shanghai Cancer Institute, Renji Hospital affiliated to Shanghai JiaoTong University. Dr. Li is Standing Committee of Gene Therapy Association of China, China Translational Medicine Union, and Shanghai Immunology Association. Dr. Li graduated from Hunan Medical University (Now XiangYa School of Medicine, Central South University) in 1997. He further acquired his PhD degree from Fudan University in 2005.